ArriVent Appoints Kristine Peterson to its Board of Directors

NEWTON SQUARE, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of

Related Keywords

Canada ,Canadian ,Eyepoint Pharma ,Bristol Myers Squibb ,Kristine Peterson ,Bing Yao ,Immunogen Inc ,Arrivent Biopharma Inc ,Paratek Pharmaceuticals ,University Of Illinois At Urbana Champaign ,Immunocore Inc ,Enanta Pharmaceuticals ,Valeritas Inc ,Operations For Biovail Corporation ,Amarin Corporation ,Exchange Commission On ,Johnson ,Exchange Commission ,Company Group ,Vent Biopharma ,Chief Executive Officer ,Board Member ,Company Group Chair ,Senior Vice President ,Commercial Operations ,Biovail Corporation ,Private Securities Litigation Reform Act ,Region ,